China Universal Asset Management Company’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25.8K Buy
2025
Q1
$18.1K Sell
2024
Q4
$39.8K Buy
2023
Q4
Sell
2023
Q3
$5.36K Buy
2023
Q2
$6.14K Sell
2023
Q1
$7.58K Buy
2022
Q4
$9.96K Buy
2022
Q3
$20K Buy